Acumen. Leadership. Expertise.
The Astute Medical team has extensive industry experience and insights on validation of biomarkers. Our senior leadership team offers expertise in developing, manufacturing and commercialization of products in the health care field.




Ya-Ling King | Senior Director, Quality Assurance
Ravi Vijayendran | VP of Product Development and Manufacturing
Joe Anderberg | VP of Emerging Technologies
Dr. McPherson has over 25 years’ experience in research and development. He has over 25 issued U.S. patents in areas ranging from immunoassay platforms to novel biomarker content in a variety of disease areas.
Prior to co-founding Astute Medical in 2007, Dr. McPherson was vice president of research and development at Biosite Inc., a leading diagnostics company acquired by Inverness Medical Innovations. During his 14-year tenure at Biosite, Dr. McPherson led the company’s 85-person research and development team in its hunt for new biomarkers for disease. The team successfully developed and launched eight FDA-cleared products, which included novel diagnostics for congestive heart failure and the first quantitative point-of-care troponin test for myocardial infarction. He played a key role in the development and commercialization of Biosite’s Triage® Meter Platform and the Triage® family of point-of-care immunoassay products.
Dr. McPherson was a post-graduate research physicist at the University of California, San Diego, where he conducted and published research on the biophysics of photosynthesis.
He earned a doctorate in physics (biophysics) from the University of California, San Diego and a bachelor’s in physics from the University of California, Santa Cruz.
Dr. Ravi Vijayendran is a leader and expert in the development, technology transfer, and manufacturing of rapid test and point-of-care in-vitro diagnostic products. He has 15 years of experience in the research and development of in-vitro diagnostic and life science products. Dr. Vijayendran leads the development and oversees the manufacturing of Astute Medical’s NephroCheck and other innovative, biomarker-based diagnostic products.
Prior to joining Astute Medical, Dr. Vijayendran held positions at Biosite, Inc. and Alere, Inc., where he led the technical development of cardiovascular immunodiagnostic products from research and development through product commercialization. He also previously held a scientific position with Caliper Technologies, Corp., developing microfluidic products for the life sciences. Dr. Vijayendran holds a doctorate degree in chemical engineering from the University of Illinois and a bachelor’s degree in chemical engineering from Cornell University.
Joe Anderberg, Ph.D., has over 30 years’ experience in research and development. He has over 50 issued and pending U.S. patents in areas ranging from immunoassay methods and readers to novel biomarker content.
As an early team member of Astute Medical Inc., Dr. Anderberg built the foundations of Astute’s discovery engine.
Prior to joining Astute Medical in 2008, Dr. Anderberg was Sr. Director of Quantitative R&D at Biosite Inc., a leading diagnostics company acquired by Inverness Medical Innovations for $1.7 billion. During his 11 years at Biosite, Dr. Anderberg’s primary role was the development and commercialization of Biosite’s Triage® Meter Platform. He also was a key member of the Biomarker Discovery Team, and invented an innovative assay technology.
Prior experience includes the development of SQUID magnetometer based research instruments at Conductus Inc. and metrology tools for the X-ray Mask and Electron Beam Exposure group at AT&T Bell Laboratories.
He earned a doctorate in physics from the University of California, San Diego and a bachelor’s in physics from Harvey Mudd College.